Endpoints News Apr 6, 2026 Stipple Bio launches with $100M to find more precise targets on cancer proteins
Endpoints News Feb 11, 2026 Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial
Endpoints News Dec 9, 2025 Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs
Endpoints News Dec 1, 2025 Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success